journal
https://read.qxmd.com/read/31860377/expanding-coverage-of-oncology-drugs-in-an-aging-upper-middle-income-country-analyses-of-public-and-private-expenditures-in-chile
#1
JOURNAL ARTICLE
Veronica Vargas, Christine Leopold, Marianela Castillo-Riquelme, Jonathan J Darrow
PURPOSE: The population of Chile has aged, and in 2017, cancer became the leading cause of death. Since 2005, a national health program has expanded coverage of drugs for 13 types of cancer and related palliative care. We describe the trends in public and private oncology drug expenditures in Chile and consider how increasing expenditures might be addressed. METHODS: We analyzed total quarterly drug expenditures for 131 oncology drugs from quarter (Q)3 2012 until Q1 2017, including public and private insurance payments and patient out-of-pocket spending...
December 2019: Journal of Global Oncology
https://read.qxmd.com/read/31834833/identifying-and-prioritizing-family-education-needs-at-pediatric-oncology-centers-in-central-america-and-mexico
#2
MULTICENTER STUDY
Erin McCann, Soad Fuentes-Alabí, Federico Antillón, Lourdes Vega-Vega, Maria Sabina Sanchez, Irini Albanti
METHODS: A qualitative study involving 72 in-person interviews and 4 focus groups was conducted using a semistructured interview guide. Key informants included family members, physicians, nurses, psychosocial providers, foundation leadership, volunteers, and communication professionals. The study sites included pediatric oncology centers in El Salvador, Guatemala, Mexico, and Panama. NVivo was used for thematic analysis. RESULTS: Across all sites, parents had common questions and educational needs...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31834832/does-interim-pet-scan-after-2-cycles-of-abvd-predict-outcome-in-hodgkin-lymphoma-real-world-evidence
#3
MULTICENTER STUDY
Arun Seshachalam, Shashidhar V Karpurmath, Krishnakumar Rathnam, S Ganapathi Raman, Murugesan Janarthinakani, Krishna Prasad, Channappa Patil, Parameswaran Anoop, Neelesh Reddy, Satish Kumar Anumula, Sirigeri Prabhakar Roopa, Krishna Reddy Golamari, Madhav Danthala, Prasad Gunari, Basawantrao Malipatil, Bharath Rangarajan, Karthik S Udupa, Manjunath Nandennavar, Kesavan Niraimathi, Hemant Deepak Shewade
PURPOSE: Escalated BEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone) improves overall survival (OS) in patients with Hodgkin lymphoma (HL) relative to ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) therapy. However, the associated higher cost and toxicity discourage clinicians from prescribing it. Identifying high-risk patients and administering escalated BEACOPP remains an effective strategy. We assessed the significance of interim positron emission tomography (iPET) scan after 2 cycles (iPET2) in identifying this high-risk subset...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31834831/patterns-of-care-of-cancers-and-radiotherapy-in-ethiopia
#4
JOURNAL ARTICLE
Tara Rick, Biruk Habtamu, Wondemagegnhu Tigeneh, Aynalem Abreha, Yvette van Norden, Surbhi Grover, Mathewos Assefa, Luca Incrocci
PURPOSE: Radiotherapy (RT) is an essential component of cancer treatment. There is a lack of RT services in sub-Saharan Africa as well as limited knowledge regarding clinical practices. The purpose of this study was to identify and describe the patterns for RT treatment in Ethiopia. METHODS AND MATERIALS: We performed a retrospective analysis of 1,823 patients treated with cobalt RT at a large referral hospital in Addis Ababa, Ethiopia, from May 2015 through January 2018...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31809225/swot-analysis-of-oncology-clinical-trials-in-africa-a-town-hall-report-from-the-global-congress-on-oncology-clinical-trials-in-blacks
#5
JOURNAL ARTICLE
Adaora Ezeani, Folakemi Odedina, Desiree Rivers, Omolara Fatiregun, Titilope Akinremi
Cancer is rapidly becoming a public health crisis as a result of the continued growth and ageing of the global population and will greatly affect resource-limited low- to middle-income countries. It is widely acknowledged that research should be conducted within countries that will bear the greatest burden of disease, and Africa has the unparalleled opportunity to lead the way in developing clinical trials to improve the health of its countries. In 2018, the inaugural Global Congress on Oncology Clinical Trials in Blacks was organized to address the global challenges of clinical trials for oncology among black populations...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31809224/randomized-double-blind-pharmacokinetic-equivalence-trial-comparing-drl-rituximab-with-mabthera-in-patients-with-diffuse-large-b-cell-lymphoma
#6
RANDOMIZED CONTROLLED TRIAL
Auro Viswabandya, Sandip Shah, Asis Mukhopadhyay, Rajnish Vasant Nagarkar, Sonica Sachdeva Batra, Luis Lopez-Lazaro, Suresh Kankanwadi, Alok Srivastava
PURPOSE: We sought to compare the pharmacokinetics (PKs) of DRL-rituximab (DRL_RI; potential biosimilar) and innovator rituximab MabThera (Roche, Grenzach-Wyhlen, Germany; reference medicinal product [RMP]) in patients with diffuse large B-cell lymphoma (DLBCL). Efficacy, pharmacodynamics (PDs), safety, and immunogenicity were also compared. PATIENTS AND METHODS: We conducted a double-blind, parallel-group study in patients with untreated DLBCL who were eligible to receive cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) therapy...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31794283/advanced-burkitt-lymphoma-in-sub-saharan-africa-pediatric-units-results-of-the-third-prospective-multicenter-study-of-the-groupe-franco-africain-d-oncologie-p%C3%A3-diatrique
#7
MULTICENTER STUDY
Gabrielle C Bouda, Fousseyni Traoré, Line Couitchere, Marie-Anne Raquin, Koffi M Guedenon, Angele Pondy, Claude Moreira, Mbola Rakotomahefa, Mhamed Harif, Catherine Patte
PURPOSE: To evaluate the results of an intensive polychemotherapy regimen for Burkitt lymphoma (BL) in sub-Saharan African pediatric centers. PATIENTS AND METHODS: Children with advanced-stage BL (stages II bulky, III, and IV) treated with the GFAOP-Lymphomes Malins B (GFALMB) 2009 protocol in 7 centers between April 2009 and September 2015 were prospectively registered. Treatment regimen contained a prephase with cyclophosphamide followed by 2 induction courses (cyclophosphamide, vincristine, prednisone, high-dose methotrexate [HDMTX]), 2 consolidation courses (cytarabine, HDMTX), and a maintenance phase only for stage IV...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31774713/cluster-randomized-trial-to-facilitate-breast-cancer-early-diagnosis-in-a-rural-district-of-rwanda
#8
JOURNAL ARTICLE
Lydia E Pace, Jean Marie Vianney Dusengimana, Lawrence N Shulman, Lauren E Schleimer, Cyprien Shyirambere, Christian Rusangwa, Gaspard Muvugabigwi, Paul H Park, ChuanChin Huang, Jean Bosco Bigirimana, Vedaste Hategekimana, Vestine Rugema, Aline Umwizerwa, Nancy L Keating, Tharcisse Mpunga
PURPOSE: Feasible and effective strategies are needed to facilitate earlier diagnosis of breast cancer in low-income countries. The goal of this study was to examine the impact of health worker breast health training on health care utilization, patient diagnoses, and cancer stage in a rural Rwandan district. METHODS: We conducted a cluster randomized trial of a training intervention at 12 of the 19 health centers (HCs) in Burera District, Rwanda, in 2 phases. We evaluated the trainings' impact on the volume of patient visits for breast concerns using difference-in-difference models...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31774712/eliminating-deaths-from-cervical-cancer-report-of-a-panel-at-the-7th-annual-symposium-on-global-cancer-research-a-satellite-meeting-at-the-consortium-of-universities-for-global-health-10th-annual-meeting
#9
JOURNAL ARTICLE
Agnes Binagwaho, Patricia J Garcia, Babacar Gueye, J Andrew Dykens, Nothemba Simelela, Julie Torode, Gelila Goba, Maarten C Bosland
This is a summary of the presentations addressing approaches and achievements to reach the goal of eliminating cervical cancer as a global public health problem that were delivered at the 7th Annual Symposium on Global Cancer Research at the 10th Annual Consortium of Universities for Global Health Meeting in March 2019. Dr Princess Nothemba Simelela, Assistant Director-General for Family, Women, Children and Adolescents, World Health Organization, gave an introduction to the World Health Organization-led Cervical Cancer Elimination Initiative and the emerging conceptual framework and targets that will shape the global 2020 to 2030 strategy...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31774711/epidemiology-of-hematologic-malignancies-in-real-world-settings-findings-from-the-hemato-oncology-latin-america-observational-registry-study
#10
MULTICENTER STUDY
Vania Tietsche de Moraes Hungria, Carlos Chiattone, Miguel Pavlovsky, Lina M Abenoza, Gladys P Agreda, Jorge Armenta, Celso Arrais, Oscar Avendaño Flores, Fernando Barroso, Ana L Basquiera, Carmen Cao, Maria S Cugliari, Alicia Enrico, Laura M Foggliatto, Kenny M Galvez, David Gomez, Alvaro Gomez, Daniel de Iracema, Danielle Farias, Lineth Lopez, William Armando Mantilla, Deborah Martínez, Maria Jose Mela, Carlos E Miguel, Roberto Ovilla, Luis Palmer, Carolina Pavlovsky, Christian Ramos, Guillermina Remaggi, Rodrigo Santucci, Sergio Schusterschitz, Claudia Lucia Sossa, Elena Tuna-Aguilar, Jorge Vela, Telma Santos, Odin de la Mora, Gerardo Machnicki, Mariana Fernandez, Paula Barreyro
PURPOSE: Limited information is available on multiple myeloma (MM), chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma (NHL) management in Latin America. The primary objective of the Hemato-Oncology Latin America (HOLA) study was to describe patient characteristics and treatment patterns of Latin American patients with MM, CLL, and NHL. METHODS: This study was a multicenter, retrospective, medical chart review of patients with MM, CLL, and NHL in Latin America identified between January 1, 2006, and December 31, 2015...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31770067/cross-cultural-validity-study-of-a-medical-education-leadership-competencies-instrument-in-latin-american-physicians-a-multinational-study
#11
JOURNAL ARTICLE
Max S Mano, Rafaela Gomes, Gustavo Werutsky, Carlos H Barrios, Gustavo Nader Marta, Cynthia Villarreal-Garza, Antonio Luiz Frasson, Cinthya Sternberg, Renan Clara, Sergio D Simon, Fadil Çitaku, Marianne Waldrop, Claudio Violato, Don Zillioux, Yawar Hayat Khan
PURPOSE: Physicians rarely receive formal training in leadership skills. Çitaku and colleagues have identified a set of leadership competencies (LCs) providing validity evidence in North American (NA) and European Union (EU) medical education institutions. We aim to apply this same survey to a sample of Latin American (LA) medical leaders from the oncology community and related areas, compare the results with those of the previous survey, and perform subgroup analyses within the LA cohort...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31770052/breast-cancer-care-quality-in-south-africa-s-public-health-system-an-evaluation-using-american-society-of-clinical-oncology-national-quality-forum-measures
#12
JOURNAL ARTICLE
Daniel S O'Neil, Wenlong Carl Chen, Oluwatosin Ayeni, Sarah Nietz, Ines Buccimazza, Urishka Singh, Sharon Čačala, Laura Stopforth, Maureen Joffe, Katherine D Crew, Judith S Jacobson, Alfred I Neugut, Paul Ruff, Herbert Cubasch
PURPOSE: The quality of breast cancer care in sub-Saharan Africa contributes to the region's dismal breast cancer mortality. ASCO has issued quality measures focusing on delivery of adjuvant chemotherapy, radiotherapy, and endocrine therapy. We applied these measures in five South African public hospitals and analyzed factors associated with care concordance. MATERIALS AND METHODS: Among 1,736 women with breast cancer who were enrolled in the South African Breast Cancer and HIV Outcomes study over 24 months, we evaluated care using ASCO's three measures...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31770048/to-tell-or-not-to-tell-exploring-the-preferences-and-attitudes-of-patients-and-family-caregivers-on-disclosure-of-a-cancer-related-diagnosis-and-prognosis
#13
JOURNAL ARTICLE
Arunangshu Ghoshal, Naveen Salins, Anuja Damani, Jayeeta Chowdhury, Arundhati Chitre, Mary Ann Muckaden, Jayita Deodhar, Rajendra Badwe
PURPOSE: To understand the preferences and attitudes of patients and family caregivers on disclosure of cancer diagnosis and prognosis in an Indian setting. METHODS: Overall, 250 adult patients with cancer and 250 family caregivers attending the outpatients of a tertiary cancer hospital for the first time were recruited purposively. The mean ages of patients and caregivers were 49.9 years (range, 23-80 years) and 37.9 years (range, 19-67 years), respectively. Separately, they completed prevalidated, close-ended preference questions and were interviewed for open-ended attitude questions...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31756139/landscape-of-global-oncology-research-and-training-at-national-cancer-institute-designated-cancer-centers-results-of-the-2018-to-2019-global-oncology-survey
#14
JOURNAL ARTICLE
Rachel M Abudu, Mishka K Cira, Doug H M Pyle, Kalina Duncan
PURPOSE: The National Cancer Institute (NCI)-Designated Cancer Centers (NDCCs) are active in global oncology research and training, leading collaborations to support global cancer control. To better understand global oncology activities led by NDCCs, the NCI Center for Global Health collaborated with ASCO to conduct the 2018/2019 NCI/ASCO Global Oncology Survey of NDCCs. METHODS: Seventy NDCCs received a two-part survey that focused on global oncology programs at NDCCs and non-National Institutes of Health (NIH)-funded global oncology projects with an international collaborator led by the NDCCs...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31756138/outcomes-of-refractory-and-relapsed-hodgkin-lymphoma-with-autologous-stem-cell-transplantation-a-single-institution-experience
#15
JOURNAL ARTICLE
Rabia Wali, Haleema Saeed, Naveed Patrus, Shehla Javed, Saadiya Javed Khan
PURPOSE: Hodgkin lymphoma is the most common cancer in children, adolescents, and young adults. Overall survival is approximately 80% to 90%. A subset of these patients has refractory disease or experience disease relapse. Conventional salvage therapies and autologous stem-cell transplantation is usually considered the standard of care for these patients. Our analysis reports outcomes in these patients. PATIENTS AND METHODS: After institutional review board approval, a retrospective analysis of patients with Hodgkin lymphoma who were up to 18 years of age and who had refractory or relapsed disease at Shaukat Khanum Memorial Cancer Hospital and Research Centre from September 2009 to December 2013 was performed...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31756131/mutational-profile-of-driver-genes-in-brazilian-melanomas
#16
JOURNAL ARTICLE
Anna Luiza S A Vicente, Camila S Crovador, Graziela Macedo, Cristovam Scapulatempo-Neto, Rui M Reis, Vinicius L Vazquez
PURPOSE: Mutation testing of the key genes involved in melanoma oncogenesis is now mandatory for the application of targeted therapeutics. However, knowledge of the mutational profile of melanoma remains largely unknown in Brazil. PATIENTS AND METHODS: In this study, we assessed the mutation status of melanoma driver genes BRAF , NRAS , TERT , KIT , and PDGFRA in a cohort of 459 patients attended at Barretos Cancer Hospital between 2001 and 2012. We used polymerase chain reaction followed by Sanger sequencing to analyze the hot spot mutations of BRAF exon 15 (V600E), NRAS (codons 12/13 and 61), TERT (promoter region), KIT (exons 9, 11, 13, and 17), and PDGFRA (exons 12, 14, and 18) in tumors...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31730380/advanced-stage-at-diagnosis-and-worse-clinicopathologic-features-in-young-women-with-breast-cancer-in-brazil-a-subanalysis-of-the-amazona-iii-study-gbecam-0115
#17
JOURNAL ARTICLE
Maria Alice Franzoi, Daniela D Rosa, Facundo Zaffaroni, Gustavo Werutsky, Sérgio Simon, José Bines, Carlos Barrios, Eduardo Cronemberger, Geraldo Silva Queiroz, Vladmir Cordeiro de Lima, Ruffo Freitas Júnior, José Couto, Karla Emerenciano, Heloísa Resende, Susanne Crocamo, Tomás Reinert, Brigitte Van Eyli, Yeni Nerón, Vanessa Dybal, Nicolas Lazaretti, Rita de Cassia Costamillan, Diocésio Alves Pinto de Andrade, Clarissa Mathias, Giovana Zerwes Vacaro, Giuliano Borges, Alessandra Morelle, Carlos Alberto Sampaio Filho, Max Mano, Pedro E R Liedke
PURPOSE: Breast cancer (BC) in young women is uncommon and tends to present with more aggressive characteristics. To better understand and characterize this scenario in Brazil through real-world data, we performed a subanalysis of AMAZONA III study (ClinicalTrials.gov identifier: NCT02663973). METHODS: The AMAZONA III study (GBECAM 0115) is a prospective registry that included 2,950 women newly diagnosed with invasive BC in Brazil from January 2016 until March 2018 at 22 sites...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31721627/pattern-of-presentation-of-patients-with-breast-cancer-in-iraq-in-2018-a-cross-sectional-study
#18
JOURNAL ARTICLE
Mohammed Tareq Mutar, Mohammed Saleh Goyani, Ali Mohammed Had, Aqeel Shakir Mahmood
PURPOSE: This study aims to describe the pattern of presentation of Iraqi female patients with breast cancer by assessing the grades and stages of their cancers at the time of presentation, to identify patients' main complaints, and to discover whether there is any difference in presentation between patients in Iraq and those in other countries. PATIENTS AND METHODS: This is a retrospective cross-sectional study that was performed in the National Center of Cancer in 2018...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31702947/public-awareness-and-perceptions-of-radiotherapy-and-their-influence-on-the-use-of-radiotherapy-in-dar-es-salaam-tanzania
#19
JOURNAL ARTICLE
Geofrey F Soko, Anthony B Burambo, Mpanda M Mngoya, Burhani A Abdul
PURPOSE: Misconceptions associated with radiotherapy (RT) may affect the patient's choice to undergo or not undergo RT. In this study, the level of awareness and perceptions about radiation and RT, as well as their impact on the use of RT, were assessed. MATERIALS AND METHODS: A cross-sectional survey was conducted in the city of Dar es Salaam, Tanzania, between November 2018 and March 2019. Stratified sampling was used to obtain a sample of 629 participants from 4 strata, including 53 patients with cancer, 129 health professionals, 127 medical and nursing students, and 320 respondents from the general public...
November 2019: Journal of Global Oncology
https://read.qxmd.com/read/31702946/improving-cancer-outcomes-in-low-and-middle-income-countries
#20
JOURNAL ARTICLE
Richard R Love
No abstract text is available yet for this article.
November 2019: Journal of Global Oncology
journal
journal
53332
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.